Loading the company…
Loading the company…
In the last ten years FDA made 4 decisions for Emblation (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2025 (1). The latest was on 2025-08-08.
| Family | Decisions on record |
|---|---|
| Tumor ablation | 4 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2025-08-08 | 510(k) | K250718 | swiftPro System (SWF-SPS); Swift System (SWF-SYS) |
| 2024-04-23 | 510(k) | K240518 | swiftPro System |
| 2023-05-04 | 510(k) | K222388 | swiftPro System |
| 2018-10-18 | 510(k) | K181941 | Swift System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Emblation.